戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ulous meningitis, and two as not tuberculous meningitis.
2 s on healthcare-associated ventriculitis and meningitis.
3  MTB/RIF Ultra (Xpert Ultra) for tuberculous meningitis.
4 se is untested in patients with cryptococcal meningitis.
5 ed to establish nonhematogenous pneumococcal meningitis.
6 al invasive infections, including sepsis and meningitis.
7 re aggressive treatment than anthrax without meningitis.
8 iagnostic and prognostic factors for anthrax meningitis.
9 umococcus) is the primary cause of bacterial meningitis.
10 T) status for people with a first episode of meningitis.
11 rough the BBB into the brain to cause lethal meningitis.
12 isease severity and outcome in patients with meningitis.
13 tocida is a rare cause of neonatal bacterial meningitis.
14 the blood brain barrier, causing cause fatal meningitis.
15 gens responsible for most cases of bacterial meningitis.
16 s comprising 373 patients with meningococcal meningitis.
17 most frequent and critical type of bacterial meningitis.
18 re more frequently associated with sepsis or meningitis.
19 nfluence the pathophysiology of pneumococcal meningitis.
20  is the second most common cause of neonatal meningitis.
21 with morbidity and mortality of pneumococcal meningitis.
22 GBS) is a major cause of neonatal sepsis and meningitis.
23 ring function in a rat model of pneumococcal meningitis.
24 -1 has the potential to prevent pneumococcal meningitis.
25 GBS infection include sepsis, pneumonia, and meningitis.
26 ents (5.5%) had a suspected ventriculitis or meningitis.
27 o apply to meningococcal meningitis or viral meningitis.
28 ile sites to cause bloodstream infection and meningitis.
29  years with symptoms and signs suggestive of meningitis.
30 confer protection against cardiac damage and meningitis.
31 a for 325 children hospitalized with E. coli meningitis.
32 ens from patients and mice with pneumococcal meningitis.
33 lood-brain barrier during the development of meningitis.
34 al effect on confirmed group A meningococcal meningitis.
35 o are developing and dying from cryptococcal meningitis.
36 isms of CNS entry as well as the severity of meningitis.
37  in the early host response during bacterial meningitis.
38 as 50% (7 of 14) with 1:160-1:320 titers had meningitis.
39 ological diseases including encephalitis and meningitis.
40 al diagnostic test for suspected tuberculous meningitis.
41 ed as significant risk factors for bacterial meningitis.
42 percentage of infants with NDI following GBS meningitis.
43 s initial diagnostic testing for tuberculous meningitis.
44 cipients), one case of Haemophilus influenza meningitis (1% rabies-vaccine recipients), and one case
45 h fungal (13), arboviral (10), and bacterial meningitis (7).
46 nisters of health declared the prevention of meningitis a high priority and asked the World Health Or
47 us pneumoniae is the main cause of bacterial meningitis, a life-threating disease with a high case fa
48 mmon pathogens accounting for most bacterial meningitis, a serious global infectious disease with hig
49 rubii is the causative agent of cryptococcal meningitis, a significant source of mortality in immunoc
50                              Acute bacterial meningitis (ABM) in adults residing in resource-poor cou
51                 In suspected acute bacterial meningitis (ABM), cerebral computerized tomography (CT)
52 eudosyrinx, without inflammatory evidence of meningitis activity.
53                              Trends in viral meningitis admissions have changed substantially over th
54 elop healthcare-associated ventriculitis and meningitis after the following procedures or situations:
55                 Admissions for mumps-related meningitis almost disappeared following introduction of
56 with healthcare-associated ventriculitis and meningitis (American Academy of Neurology, American Asso
57 ight into the seasonal dynamics of bacterial meningitis and add to knowledge about the global epidemi
58       Six patients had recurrent episodes of meningitis and all recovered without any neurologic sequ
59 r of morbidity and mortality of pneumococcal meningitis and also suggests a potential role for MIF as
60 a foodborne pathogen that causes septicemia, meningitis and chorioamnionitis and is associated with h
61  Rapid diagnosis and treatment of infectious meningitis and encephalitis are critical to minimize mor
62                                              Meningitis and encephalitis are potentially life-threate
63 sts for the most common causes of infectious meningitis and encephalitis have the potential for high
64 ers to diagnosis, and current best tests for meningitis and encephalitis in developed countries.
65 es that are transmitted by insects and cause meningitis and encephalitis in subsets of individuals in
66         Viruses are the most common cause of meningitis and encephalitis in the United States and are
67 est Nile virus (WNV) is an emerging cause of meningitis and encephalitis in the United States.
68      Histological analysis revealed signs of meningitis and encephalitis, characteristic of severe hu
69 rapy for children with signs and symptoms of meningitis and encephalitis.
70 sease and severe clinical syndromes, such as meningitis and endocarditis.
71 ial reductions in the incidence of suspected meningitis and epidemic risk, and a substantial effect o
72 ide cohort of 405 patients with pneumococcal meningitis and in 329 controls matched for age, gender,
73 ger, to determine risk factors for bacterial meningitis and invasive bacterial disease.
74 ynx and the causative agent of meningococcal meningitis and meningococcemia, is capable of invading a
75 neumococcus) is a leading cause of bacterial meningitis and neurological sequelae in children worldwi
76 a meningitidis is a major cause of bacterial meningitis and sepsis worldwide.
77 r example, tuberculosis, syphilis, bacterial meningitis and sepsis), fungal (for example, cryptococca
78 ontal genetic exchange, are a major cause of meningitis and septicaemia worldwide.
79      Neisseria meningitidis causes bacterial meningitis and septicemia.
80 mmensal that can also cause life-threatening meningitis and septicemia.
81 o knowledge about the global epidemiology of meningitis and the host, environment, and pathogen chara
82 nts with a first episode of culture-positive meningitis and two or more CSF cultures.
83 osuppression who developed recurrent aseptic meningitis and underwent brain biopsy revealing a diagno
84 th strains, oral infection resulted in focal meningitis and ventriculitis with recruitment of inflamm
85 ng patients with HIV-associated cryptococcal meningitis and was associated with more adverse events a
86 d sepsis), fungal (for example, cryptococcal meningitis) and parasitic (for example, malaria, neurocy
87 ents (5.5%) had a confirmed ventriculitis or meningitis, and 15 patients (5.5%) had a suspected ventr
88 nted with pneumonia, 78 (35%) presented with meningitis, and 16 (7%) had other clinical conditions.
89 sser's disease in swine, with polyserositis, meningitis, and arthritis.
90 sease (IPD) is a leading cause of pneumonia, meningitis, and bacteremia in children.
91 sRNA flavivirus that can cause encephalitis, meningitis, and death in humans and mice.
92  need for inotropes, mechanical ventilation, meningitis, and death, was unchanged after introduction
93 on in pregnant women, as well as septicemia, meningitis, and gastroenteritis, primarily in immunocomp
94 humanized mice was characterized by gliosis, meningitis, and meningoencephalitis, and glial cells wer
95 . coli K1 is a novel pathogenic mechanism in meningitis, and pharmacological upregulation of PPAR-gam
96 3 that caused meningitis, septicemia without meningitis, and septicemia with meningitis, respectively
97 us meningitis, three as possible tuberculous meningitis, and two as not tuberculous meningitis.
98 onths after discharge with symptoms of acute meningitis, and was found to have Ebola virus in cerebro
99 ines for epidemic diseases, such as cholera, meningitis, and yellow fever, have become common over th
100 sis a major endemic pathogen of pigs causing meningitis, arthritis, and other diseases.
101                                 Cryptococcal meningitis associated with human immunodeficiency virus
102 viding new insights into the pathogenesis of meningitis-associated hearing loss that reveal new start
103 ion of West Africa has the highest bacterial meningitis attack and case fatality rate in the world.
104  surveillance data for nine countries in the meningitis belt (Benin, Burkina Faso, Chad, Cote d'Ivoir
105 A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduc
106 ies, including from 47 countries outside the meningitis belt in sub-Saharan Africa.
107 ia meningitidis serogroup A epidemics in the meningitis belt of sub-Saharan Africa, a meningococcal s
108 ng mass vaccination campaigns in the African meningitis belt with group A meningococcal conjugate vac
109  conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance net
110 rm control of MenA meningitis in the African meningitis belt.
111 s in the sub-Saharan region of Africa in the meningitis belt.
112 be developed and introduced into the African meningitis belt.
113 auses of bacterial meningitis in the African meningitis belt.
114 ant determinant of mortality in cryptococcal meningitis, but its use in aiding clinical decision maki
115 ons were consistent with chronic lymphocytic meningitis, but no definitive cause was identified.
116 ay contribute to susceptibility of bacterial meningitis, but which genes contribute to the susceptibi
117                            Pneumococci cause meningitis by invading the blood and penetrating the blo
118 assified as probable or definite tuberculous meningitis by uniform case definition, excluding Xpert U
119 cture (LP) in adults with community-acquired meningitis (CAM).
120 study in 469 community-acquired pneumococcal meningitis cases and 2072 population-based controls from
121  From Jan 1 to June 30, 2015, 9367 suspected meningitis cases and 549 deaths were reported in Niger.
122                   The incidence of suspected meningitis cases declined by 57% (95% CI 55-59) in vacci
123 ounted for 73% of the estimated cryptococcal meningitis cases in 2014 (162 500 cases [95% CI 113 600-
124           In the United States, cryptococcal meningitis causes approximately 3400 hospitalizations an
125 ters >1:640, 96% (27 of 28) had cryptococcal meningitis (cerebrospinal fluid CRAG-positive) whereas 5
126  samples, including bacteremia and bacterial meningitis classified as IBIs.
127                      Diagnosing coccidioidal meningitis (CM) can be problematic owing to its infreque
128 eficiency virus/AIDS-associated cryptococcal meningitis (CM) frequently experience clinical deteriora
129                                 Coccidioidal meningitis (CM) has high morbidity, and adjunctive measu
130                                 Coccidioidal meningitis (CM) is a devastating complication of coccidi
131                                 Cryptococcal meningitis (CM) is one of the most common causes of AIDS
132 rmine the national incidence of cryptococcal meningitis (CM), and describe characteristics of cases d
133  defaulted from care, died from cryptococcal meningitis (CM).
134  cases) for probable or definite tuberculous meningitis compared with 43% (23-66; 10/23) for Xpert an
135                          Escherichia coli K1 meningitis continues to be a major threat to neonatal he
136 e understanding of global seasonal trends in meningitis could be used to design more effective preven
137 36%) cases with systemic anthrax met anthrax meningitis criteria.
138 temporal manner may indicate early bacterial meningitis development in neurosurgical patients, enabli
139 revent pneumococcal entry into the brain and meningitis development.
140 ioidal, so CSF BG screening can be useful in meningitis diagnosis.
141 en by participants with CSF WCC <5/microL at meningitis diagnosis: 28% (10/36) of such persons in the
142 uid data from all 37 laboratories performing meningitis diagnostics in Botswana were collected from t
143 umber of severe pathologies, such as aseptic meningitis, dilated cardiomyopathy, type I diabetes, par
144 e describe the first 2 cases of eosinophilic meningitis due to Paragonimus kellicotti.
145                                              Meningitis due to vaccine serotypes nearly disappeared i
146 d assessment tool for screening patients for meningitis during an anthrax mass casualty incident.
147           HIV-infected adults with suspected meningitis (eg, headache, nuchal rigidity, altered menta
148                                The FilmArray Meningitis/Encephalitis (ME) Panel is a multiplexed in v
149 vely assess the performance of the FilmArray meningitis/encephalitis panel compared to conventional m
150                          We report the first meningitis epidemic in Niger since the nationwide introd
151 de vaccines had been used to control African meningitis epidemics for >30 years but with little or mo
152        After the major group A meningococcal meningitis epidemics in 1996-1997 (250,000 cases and 25,
153  better immunization strategies to eliminate meningitis epidemics in Africa.
154 te vaccine was developed to eliminate deadly meningitis epidemics in sub-Saharan Africa.
155  infect the central nervous system and cause meningitis following the natural route of infection in m
156 uated 129 HIV-infected adults with suspected meningitis for tuberculosis.
157 nsible for 67.3% of 55 cases of eosinophilic meningitis from a cohort of 1,690 adult patients with CN
158           Hospital admission rates for viral meningitis from Jan 1, 1968, to Dec 31, 1985, varied ann
159 y, Toscana virus is the most common cause of meningitis from May to October.
160             We developed the first bacterial meningitis global database by compiling monthly incidenc
161  600-282 400) incident cases of cryptococcal meningitis globally in 2014.
162                 No persons with cryptococcal meningitis had negative fingersticks.
163 ir and vancomycin during management of acute meningitis has been explored.
164 eir role in the pathogenesis of pneumococcal meningitis has not been addressed.
165         A substantial reduction in bacterial meningitis has occurred in the UK following successful i
166 roup B (MnB) is a leading cause of bacterial meningitis; however, MnB is most commonly associated wit
167 occus (GBS) is the leading cause of neonatal meningitis; however, the molecular mechanisms that regul
168 evaluated the prevalence of ventriculitis or meningitis in 13 Italian ICUs.
169 rospinal fluid samples detected lymphomatous meningitis in 2 patients.
170  composite standard, we detected tuberculous meningitis in 22 (17%) of 129 participants.
171 med to describe features of Escherichia coli meningitis in a large population of children and the mol
172     Cryptococcus is the most common cause of meningitis in adults living with HIV in sub-Saharan Afri
173 t emerged as an important cause of bacterial meningitis in adults.
174 s emerged as an important cause of bacterial meningitis in adults.
175 yptococcus is the most common cause of adult meningitis in Africa.
176 c) was developed to control epidemic group A meningitis in Africa.
177  several decades, the incidence of bacterial meningitis in children has decreased but there remains a
178                               Most childhood meningitis in developed countries is now caused by virus
179         Long-term trends in paediatric viral meningitis in England have not previously been reported.
180 ological trends over time in childhood viral meningitis in England.
181 hogen that can cause life-threatening fungal meningitis in immunocompromised individuals.
182 lous meningitis (TBM) is a frequent cause of meningitis in individuals with human immunodeficiency vi
183 the treatment of HIV-associated cryptococcal meningitis in Mbarara, Uganda.
184 ) is a leading cause of bacterial sepsis and meningitis in newborns.
185  the progression and outcome of pneumococcal meningitis in Rag1(-/-) mice lacking functional B and T
186 mortality among patients with other forms of meningitis in some populations, but their use is unteste
187 acteristics of nontyphoidal Salmonella (NTS) meningitis in South Africa, where human immunodeficiency
188 accounting for 33%-63% of all cases of adult meningitis in sub-Saharan Africa and >500 000 deaths ann
189 ation strategy for long-term control of MenA meningitis in the African meningitis belt.
190  X are among the leading causes of bacterial meningitis in the African meningitis belt.
191 igns at presentation independently predicted meningitis in the derivation cohort and were tested as a
192 can describe the typical annual incidence of meningitis in the prevaccine era, with irregular epidemi
193 ngitidis has been a major cause of bacterial meningitis in the sub-Saharan region of Africa in the me
194 lt patients with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda
195 enAfriVac), in 2010, we analyzed the data on meningitis incidence and case fatality from countries re
196 nnual age-specific admission rates for viral meningitis, including specific viral aetiologies, in chi
197                                      Anthrax meningitis is a common manifestation of B. anthracis inf
198                                 Cryptococcal meningitis is a metric of HIV treatment programme failur
199                                          GBS meningitis is an important risk factor for moderate to s
200 of CSF BDG testing for other types of fungal meningitis is needed.
201       Although the pathogenesis of bacterial meningitis is not completely understood, knowledge of ba
202 ical features alone cannot determine whether meningitis is present and analysis of cerebrospinal flui
203                                 Pneumococcal meningitis is the most frequent and critical type of bac
204                              Acute bacterial meningitis is widely considered to result from bacteremi
205 ensis, while a primary cause of eosinophilic meningitis, is rarely a cause of FUO.
206 sing home, recent surgery, septic shock, NF, meningitis, isolated bacteremia, pneumonia, emm type 1 o
207 nd for patients with endocarditis, bacterial meningitis, lymphoma/leukemia, HIV/AIDS, internal organ
208                   Using a bacteremia-derived meningitis model and mutant mice, as well as antibodies
209                                         In a meningitis model, MRP14-deficient mice showed a better r
210 er as cases of encephalopathy, encephalitis, meningitis, myelitis, and seizures have also been report
211 ty presented with septicemia (n = 63 [49%]), meningitis (n = 16 [12%]) or both (n = 21 [16%]); howeve
212 e occurrence of serious infection (sepsis or meningitis), necrotizing enterocolitis, or mortality dur
213 ission had a sensitivity for finding anthrax meningitis of 89% (83%) in the adult (pediatric) validat
214 ensively assess seasonal trends in bacterial meningitis on a global scale.
215  All 18 studies followed up survivors of GBS meningitis; only 5 of these studies also followed up sur
216            Adult patients (>/=18 years) with meningitis or encephalitis by International Classificati
217 ement decisions, and outcomes of adults with meningitis or encephalitis in the United States (US) are
218               A total of 26429 patients with meningitis or encephalitis were identified.
219 ion, it may disseminate to the CNS and cause meningitis or meningoencephalitis.
220 n can mimic other conditions such as aseptic meningitis or pituitary adenomas.
221 symptoms, clinical presentation of suspected meningitis or pneumonia, and evidence of radiographic pn
222 tions did not seem to apply to meningococcal meningitis or viral meningitis.
223 pneumococcal (n = 553), or viral (n = 1,433) meningitis or with herpes simplex encephalitis (n = 115)
224 R = 8.3; CI, 4.9-13.9; P < .0001), bacterial meningitis (OR = 3.8; CI, 1.2-12.0; P = .023), fungal me
225 s (OR = 3.8; CI, 1.2-12.0; P = .023), fungal meningitis (OR = 59.1; CI, 14.1-247.8; P < .0001), inter
226 e-threatening infections, such as pneumonia, meningitis, or sepsis.
227  the Ebola outbreak response and measles and meningitis outbreaks; and strengthening the integrated d
228 py in immunocompromised patients with herpes meningitis (P < .05), but not in the 27 patient-episodes
229   With fluconazole 1200 mg/d therapy, 68% of meningitis patients (23 of 34) died within 3 months.
230 brospinal fluid (CSF) samples from suspected meningitis patients of all ages were examined by traditi
231 ity pension in former meningococcal or viral meningitis patients versus members of the comparison coh
232 al conjugate vaccine (PCV13) on pneumococcal meningitis (PM) in US children is unknown.
233 loss is an important sequela of pneumococcal meningitis (PM), occurring in up to 30% of survivors.
234 up to 30% of patients surviving pneumococcal meningitis (PM).
235 jor global public health problems, including meningitis, pneumonia and septicaemia.
236 brospinal fluid from patients with suspected meningitis, presenting to Queen Elizabeth Central Hospit
237                       Most patients with HSV meningitis rapidly improve, but immunocompromised hosts
238         In 6 episodes (14.3%), patients with meningitis received no antivirals, whereas the remaining
239 ances in antimicrobial therapy, pneumococcal meningitis remains a life-threatening disease.
240                                 Cryptococcal meningitis remains a significant cause of death among hu
241  clear, the role of antiviral therapy in HSV meningitis remains controversial.
242            Plasma CRAG titers >1:160 predict meningitis, requiring more intensive antifungal therapy.
243 were drafted at an international tuberculous meningitis research meeting organized by the Oxford Univ
244 emia without meningitis, and septicemia with meningitis, respectively.
245        Altered mental status in cryptococcal meningitis results in poorer survival, but underlying ca
246  In this large study of 325 cases of E. coli meningitis, risk factors of severe disease or death were
247 e used in the derivation of the Malawi Adult Meningitis Score (MAMS) nomogram.
248 vity had a latitudinal trend, with bacterial meningitis seasons peaking during the winter months in c
249 acteria causes a range of diseases including meningitis, septicaemia, gonorrhoea and endocarditis, an
250 ns were classified as groups 1-3 that caused meningitis, septicemia without meningitis, and septicemi
251 erichia coli K1-mediated neonatal sepsis and meningitis, such as a strong age dependency and developm
252  compiled and analysed nationwide case-based meningitis surveillance data in Niger.
253 for the African meningitis belt, an enhanced meningitis surveillance network was established.
254                                           Of meningitis survivors, 32% (95% CI, 25%-38%) had NDI at 1
255 e variants in a gene region and pneumococcal meningitis susceptibility yielded one significant associ
256 enetic variants associated with pneumococcal meningitis susceptibility.
257 children admitted to hospital with bacterial meningitis symptoms but negative diagnosis.
258                                  Tuberculous meningitis (TBM) is a frequent cause of meningitis in in
259                                  Tuberculous meningitis (TBM) is a severe complication of tuberculosi
260                   Drug-resistant tuberculous meningitis (TBM) is difficult to diagnose and treat.
261                                  Tuberculous meningitis (TBM) is the most devastating form of tubercu
262                                  Tuberculous meningitis (TBM) is the most severe form of tuberculous
263                                  Tuberculous meningitis (TBM) leads to death or disability in half th
264                                  Tuberculous meningitis (TBM) remains a major cause of death and disa
265  high morbidity and mortality of tuberculous meningitis (TBM), but the link between inflammation and
266 ltra detected significantly more tuberculous meningitis than did either Xpert or culture.
267  of survival among patients with tuberculous meningitis than standard treatment.
268 ains that cause urinary tract infections and meningitis, they have not been linked to translocation t
269 tractive treatment strategy for cryptococcal meningitis, though the rising price may be creating acce
270 ree were categorised as probable tuberculous meningitis, three as possible tuberculous meningitis, an
271 eported severity ranges from a self-limiting meningitis to a rapidly fatal meningoencephalitis with m
272 entified the optimal cutoff value for proven meningitis to be 66 pg/ml (sensitivity, 100%; specificit
273 ficity, 94%) and that for probable or proven meningitis to be 66 pg/ml (sensitivity, 91%; specificity
274 nce data on suspected and confirmed cases of meningitis to quantify vaccine impact.
275 BIs), defined as bacteremia and/or bacterial meningitis, using complete blood cell count parameters.
276  the progression and outcome of pneumococcal meningitis, using Kaplan-Meier survival curves, bacterio
277 , PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum
278 ] cohorts), while presence of 2 or more made meningitis very likely (LR+ = 26.5 [30.0]).
279                                              Meningitis was diagnosed in nearly half the fatal cases
280                          Survival of anthrax meningitis was predicted by treatment with a bactericida
281                       Globally, cryptococcal meningitis was responsible for 15% of AIDS-related death
282                                      Anthrax meningitis was unlikely in the absence of any of these s
283 ortant role in the pathogenesis of bacterial meningitis, we examined whether functional polymorphisms
284 psies from patients who died of pneumococcal meningitis, we observe that pneumococci colocalize with
285 atients with a first episode of cryptococcal meningitis were enrolled, and their immune responses wer
286 d, 172 HIV-infected adults with cryptococcal meningitis were enrolled.
287       Annual global deaths from cryptococcal meningitis were estimated at 181 100 (95% CI 119 400-234
288 sociated with susceptibility to pneumococcal meningitis were rs139064549 on chromosome 1 in the COL11
289 o fever onset within patients with bacterial meningitis when compared with both aseptic and nonmening
290 d treatment is underutilized in pneumococcal meningitis, where it has shown to decrease mortality.
291                                    Bacterial meningitis, which is caused mainly by Neisseria meningit
292 d HIV-infected individuals with cryptococcal meningitis who presented to Mulago Hospital in Kampala,
293 lts with a clinical diagnosis of tuberculous meningitis who were admitted to one of two Vietnamese ho
294 ants, 138 (93%) had evidence of cryptococcal meningitis with a positive CSF CRAG.
295 s and in 39.3% of patients with pneumococcal meningitis, with an associated decrease in mortality (6.
296 osis of these three major types of bacterial meningitis, with high sensitivity and specificity.
297 nd 11 from patients with suspected microbial meningitis without fungal diagnosis, for (1,3)-beta-gluc
298 e smoke increased the risk of bacteremia and meningitis without prior lung infection.
299 tidis causes 500 000 cases of septicemia and meningitis worldwide annually, with approximately 200 ca
300  throat, scarlet fever, pneumonia, bacterial meningitis, yeast infections, urinary tract infections,

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top